Free Trial

TruBridge, Inc. (NASDAQ:TBRG) Shares Purchased by D. E. Shaw & Co. Inc.

TruBridge logo with Medical background

D. E. Shaw & Co. Inc. raised its holdings in TruBridge, Inc. (NASDAQ:TBRG - Free Report) by 8.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 217,539 shares of the company's stock after buying an additional 16,821 shares during the period. D. E. Shaw & Co. Inc. owned approximately 1.46% of TruBridge worth $4,290,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Truffle Hound Capital LLC acquired a new stake in shares of TruBridge in the fourth quarter valued at $5,916,000. Susquehanna International Group LLP increased its holdings in TruBridge by 343.6% during the 4th quarter. Susquehanna International Group LLP now owns 209,871 shares of the company's stock worth $4,139,000 after purchasing an additional 162,560 shares during the period. Jane Street Group LLC raised its position in TruBridge by 211.6% in the 4th quarter. Jane Street Group LLC now owns 104,331 shares of the company's stock valued at $2,057,000 after purchasing an additional 70,850 shares in the last quarter. Susquehanna Fundamental Investments LLC acquired a new stake in TruBridge in the 4th quarter valued at about $1,107,000. Finally, JPMorgan Chase & Co. boosted its stake in shares of TruBridge by 73.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 112,240 shares of the company's stock valued at $1,342,000 after buying an additional 47,507 shares during the period. Institutional investors and hedge funds own 88.64% of the company's stock.

TruBridge Stock Down 3.1%

NASDAQ TBRG traded down $0.77 during trading on Wednesday, reaching $24.15. 149,655 shares of the company's stock were exchanged, compared to its average volume of 128,624. The company has a 50 day moving average price of $25.89 and a two-hundred day moving average price of $23.14. The stock has a market cap of $362.81 million, a P/E ratio of -5.90, a price-to-earnings-growth ratio of 5.38 and a beta of 0.65. TruBridge, Inc. has a 1 year low of $8.99 and a 1 year high of $32.00. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80.

TruBridge (NASDAQ:TBRG - Get Free Report) last issued its earnings results on Friday, May 9th. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.08). The business had revenue of $87.21 million for the quarter, compared to analyst estimates of $86.21 million. TruBridge had a positive return on equity of 1.78% and a negative net margin of 17.72%. On average, equities research analysts anticipate that TruBridge, Inc. will post 0.07 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, major shareholder Pinetree Capital Ltd. acquired 34,952 shares of the company's stock in a transaction on Thursday, February 20th. The shares were bought at an average price of $27.99 per share, with a total value of $978,306.48. Following the completion of the acquisition, the insider now owns 768,250 shares in the company, valued at $21,503,317.50. This trade represents a 4.77% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Christopher L. Fowler sold 6,000 shares of TruBridge stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $25.05, for a total value of $150,300.00. Following the sale, the chief executive officer now owns 131,090 shares in the company, valued at $3,283,804.50. This trade represents a 4.38% decrease in their position. The disclosure for this sale can be found here. 10.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Cantor Fitzgerald upped their target price on shares of TruBridge from $20.00 to $29.00 and gave the stock an "overweight" rating in a research note on Tuesday, March 11th. Stephens reiterated an "equal weight" rating and set a $28.00 price target on shares of TruBridge in a report on Thursday, April 10th.

Read Our Latest Stock Report on TruBridge

TruBridge Profile

(Free Report)

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.

Featured Stories

Institutional Ownership by Quarter for TruBridge (NASDAQ:TBRG)

Should You Invest $1,000 in TruBridge Right Now?

Before you consider TruBridge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.

While TruBridge currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines